再生醫學市場規模、佔有率、成長分析（按產品、治療領域和地區）－2025 年至 2032 年產業預測

Regenerative Medicine Market Size, Share, and Growth Analysis, By Product (Cell Therapy, Gene Therapy), By Therapeutic Area (Oncology, Musculoskeletal Disorders), By Region - Industry Forecast 2025-2032

出版日期: 2025年04月01日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年全球再生醫學市場規模價值為 152 億美元，預計將從 2024 年的 173.7 億美元成長到 2032 年的 506.1 億美元，預測期內（2025-2032 年）的複合年成長率為 14.3%。

再生醫學領域正在迅速發展，利用人體的自然癒合機制來修復和再生組織和器官。這個跨學科領域利用幹細胞、組織工程、生長因子和生醫材料，提供了巨大的益處，包括針對出生缺陷和退化性疾病等疾病的個人化治療方案。隨著個人化醫療解決方案的需求不斷成長，再生醫學與個人化醫療方法無縫結合，可根據患者的遺傳因素和生活方式量身定做治療方案。這種方法不僅提高了治療效果，而且最大限度地減少了對器官移植等傳統方法的依賴，顯著改善了患者的生活品質。隨著對幹細胞技術的投資不斷增加以及市場上產品數量的不斷增加，再生醫學市場在不久的將來將實現顯著成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

Novartis AG（Switzerland）
Biogen, Inc.（USA）
Sarepta Therapeutics, Inc.（USA）
Gilead Sciences, Inc.（USA）
Amgen Inc.（USA）
Smith+Nephew（UK）
MEDIPOST Co., Ltd.（Korea）
JCR Pharmaceuticals Co., Ltd.（Japan）
Takeda Pharmaceutical Company Limited（Japan）
CORESTEM, Inc（South Korea）.
Zimmer Biomet Holdings Inc.（USA）
AbbVie Inc.（USA）
Cryolife, Inc（USA）
Stryker（USA）
Medtronic Plc（Ireland）

結論和建議

簡介目錄

Product Code: SQMIG35I2129

Global Regenerative Medicine Market size was valued at USD 15.2 billion in 2023 and is poised to grow from USD 17.37 billion in 2024 to USD 50.61 billion by 2032, growing at a CAGR of 14.3% during the forecast period (2025-2032).

The regenerative medicine sector is rapidly evolving, leveraging the body's natural healing mechanisms to repair and regenerate tissues and organs. By utilizing stem cells, tissue engineering, growth factors, and biomaterials, this multidisciplinary field presents significant advantages, including personalized treatment options for conditions such as congenital defects and degenerative disorders. As the demand for individualized healthcare solutions rises, regenerative medicine aligns seamlessly with the personalized medicine approach, which tailors treatments to patients' genetic and lifestyle factors. This approach not only enhances treatment efficacy but also minimizes reliance on traditional methods like organ transplantation, thus significantly improving patient quality of life. With increasing investments in stem cell technologies and a growing number of product launches, the regenerative medicine market is poised for substantial growth in the near future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Regenerative Medicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Regenerative Medicine Market Segments Analysis

Global Regenerative Medicine Market is segmented by Product, Therapeutic Area and region. Based on Product, the market is segmented into Cell Therapy, Gene Therapy and Tissue Engineering. Based on Therapeutic Area, the market is segmented into Oncology, Musculoskeletal Disorders, Dermatology & Wound Care, Cardiovascular Diseases, Ophthalmology, Neurology and Other Therapeutic Areas. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Regenerative Medicine Market

The global regenerative medicine market is being propelled by advancements in precision medicine, a tailored therapeutic approach that considers individual patients' genetic, environmental, and lifestyle factors. This method facilitates the development of customized treatments for rare genetic disorders, including haemophilia B, cerebral adrenoleukodystrophy, beta thalassemia, refractory multiple myeloma, and certain types of non-muscle invasive bladder cancer. As healthcare evolves, the demand for personalized medical solutions that address the unique needs of patients grows, thereby driving innovation and investment in the regenerative medicine sector. This ongoing shift towards precision therapy is expected to significantly elevate the market's growth trajectory in the coming years.

Restraints in the Global Regenerative Medicine Market

The global regenerative medicine market faces significant challenges due to ethical concerns surrounding the use of stem cells derived from human embryos. The destruction of an embryo, which is often considered a potential life, raises moral questions, even when the intention is to save an existing life. These ethical dilemmas regarding the applicability of embryonic stem cells in treatment options contribute to hesitancy and limitations within the market. As these concerns persist, they hinder broader acceptance and advancement of regenerative therapies, ultimately affecting market growth on a global scale. Thus, navigating these ethical landscapes is crucial for the future development of this promising field.

Market Trends of the Global Regenerative Medicine Market

The Global Regenerative Medicine market is witnessing a significant shift driven by advancements in stem cell therapies, which are increasingly recognized for their potential in revolutionizing treatment paradigms. As technologies evolve and clinical applications expand, stem cells are emerging as pivotal in addressing various degenerative diseases and injuries, fostering tissue regeneration and repair. This surge in popularity is bolstered by ongoing research, favorable regulatory environments, and rising investments in the biotech sector. With a growing demand for personalized medicine and innovative therapies, the regenerative medicine market is expected to continue its rapid growth trajectory, promising enhanced patient outcomes and transforming healthcare options worldwide.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Patent Analysis
Regulatory Analysis
Technology Analysis
Case Studies
Customer And Buying Criteria Analysis

Global Regenerative Medicine Market Size by Product & CAGR (2025-2032)

Market Overview
Cell Therapy
- Stem Cell Therapy
- Cell transplantations
- Stem cell therapy products
- Cell-Based Immunotherapy
Gene Therapy
Tissue Engineering

Global Regenerative Medicine Market Size by Therapeutic Area & CAGR (2025-2032)

Market Overview
Oncology
Musculoskeletal Disorders
Dermatology & Wound Care
Cardiovascular Diseases
Ophthalmology
Neurology
Other Therapeutic Areas

Global Regenerative Medicine Market Size & CAGR (2025-2032)

North America (Product, Therapeutic Area)
- US
- Canada
Europe (Product, Therapeutic Area)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Therapeutic Area)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Therapeutic Area)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Therapeutic Area)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogen, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sarepta Therapeutics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gilead Sciences, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith+Nephew (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MEDIPOST Co., Ltd. (Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JCR Pharmaceuticals Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CORESTEM, Inc (South Korea).
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cryolife, Inc (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments